Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveF. Xavier Bosch, M. Michele Manos, Mark E. Sherman et al.|JNCI Journal of the National Cancer Institute|1995Cited by 3.4k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewalPatrick Killela, Hai Yan, Luis A. Díaz et al.|Proceedings of the National Academy of Sciences|2013Cited by 1.4k
Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage LevelsAhmedin Jemal, Brenda K. Edwards, Edgar P. Simard et al.|JNCI Journal of the National Cancer Institute|2013Cited by 997
Human Papillomavirus Testing in the Prevention of Cervical CancerMark Schiffman, Philip E. Castle|JNCI Journal of the National Cancer Institute|2011Cited by 767
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderlineMark Schiffman, Luigi Buonaguro, Gary M. Clifford|Infectious Agents and Cancer|2009Cited by 457